Cytokinetics eps
WebCytokinetics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CYTK financial statements in full. ... Qtr. EPS Est.-1.21 Q4 2024: Qtr. Year Ago-0.36 Q4 ... WebApr 10, 2024 · Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks Zacks Equity Research April 10, 2024 NVO Quick Quote CYTK Quick Quote Trades from $ 1 It has …
Cytokinetics eps
Did you know?
WebFeb 24, 2024 · Cytokinetics press release (NASDAQ: CYTK): Q4 GAAP EPS of -$0.36 beats by $0.51. Revenue of $55.6M (+727.4% Y/Y) beats by $50.04M. Cash, cash equivalents and investments totaled $623.7 million... WebCytokinetics is headquartered in South San Francisco, California, the US. Headquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD)
WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with...
WebFlu-like symptoms (chills, fever, headache, fatigue, loss of appetite, nausea, vomiting) Low white blood cell counts (which increase the risk of infection) Skin rashes. … WebApr 5, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …
WebOct 14, 2024 · Cytokinetics is a member of our Medical group, which includes 1189 different companies and currently sits at #3 in the Zacks Sector Rank. ... The consensus estimate for Humana's current year EPS ...
WebCytokinetics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Compare CYTK With Other Stocks From: To: Zoom: -6 -4 -2 0 2 Trailing 12 Months the prom unruly heartWebMar 1, 2024 · Cytokinetics press release ( NASDAQ: CYTK ): Q4 GAAP EPS of -$1.45 misses by $0.24. Revenue of $1.96M (-96.5% Y/Y) misses by $4.5M. Now Read: Cytokinetics: Temper Your Expectations Of... signature spoofingWebFeb 22, 2024 · This biopharmaceutical company is expected to post quarterly loss of $1.22 per share in its upcoming report, which represents a year-over-year change of -238.9%. Revenues are expected to be $7.46... signature spellbook jace box setWebDec 31, 2024 · Analysts estimate that Cytokinetics will report an earnings per share (EPS) of $-1.21. Cytokinetics bulls will hope to hear the company announce they've not only beaten that estimate, but... signature sports bar and grillWebApr 6, 2024 · EPS-$4.25; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 10.34M 03/15/23 % of Float Shorted 11.58%; Average Volume 992.07K; ... Cytokinetics, Inc. is a biopharmaceutical company ... signature spiral sliced hamWebFeb 24, 2024 · Cytokinetics (CYTK) delivered earnings and revenue surprises of 59.55% and 931.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? signature sports flooringWebFind the latest Revenue & EPS data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) Revenue EPS Nasdaq Skip to main content signature spa with his and her loungers